Bioinformatics, Oncology, Innovative Medicines & Early Development
Jonathan Dry is Principal Scientist and global strategy lead for AstraZeneca’s world-recognised Oncology Bioinformatics team. Jonathan completed a BSc (Hons) in Biomedical Science at the University of Manchester where his research focused on the genetics of diabetes and exposed him to the richness of information in DNA that can be uncovered with computational tools. To pursue this interest, he was awarded a scholarship at the University of Exeter to study for an MSc in Bioinformatics and he graduated with distinction. Jonathan collaborated with GlaxoSmithKline to develop computational models determining the risk of recombinant protein breakdown by proteases in host cells.
Respiratory, Inflammation & Autoimmunity